Delivery Order SPE2DB24D2205-SPE2DB25FECQB
Award Date
5/19/25
Potential Completion Date
5/20/25
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,645.16, is for the delivery of IPOL VIAL 5ML pharmaceutical products. It is a firm fixed-price contract with a period of performance through May 1, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,802.00, is for the delivery of IPOL VIAL 5ML medical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of IPOL VIAL 5ML medical products. The contract has a ceiling value of $102,390.83 and an ultimate completion date of September 23, 2024. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen, through its extensive supply chain network, will provide a wide range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,270.30, is for the delivery of IPOL VIAL 5ML pharmaceutical products. It is a firm fixed price, non-set-aside contract with a performance period ending on May 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,180.20, is for the delivery of IPOL VIAL 5ML, a pharmaceutical product. The contract has a firm fixed price and is scheduled for completion by May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $42,694.00, is for the procurement of IPOL VIAL 5ML medical products. This is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of May 29, 2024. Amerisourcebergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of pharmaceutical products, specifically IPOL VIAL 5ML. The contract has a ceiling value of $1,067.35 and a total performance period through August 13, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by defense and civilian agencies...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of IPOL VIAL 5ML, a pharmaceutical product, with a ceiling value of $2,134.70. The contract has an ultimate completion date of October 7, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) vehicle between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,802.00, is for the delivery of IPOL VIAL 5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through May 7, 2025. The contract is not set-aside and represents open competition. Amerisourcebergen Drug Corp is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of 4564628204 IPOL VIAL 5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $10,673.50, and an ultimate completion date of May 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00...